A key new finding about SDTL Life-Biofactor is brought up recently, which indicates the possible solution to human hematic hypoxia and high altitude hypoxia. SDTL is a Botanic Regulator of Life Cells originally invented by professor Shi Hui Yuan from Cosmic Dragon Biotechnology (Shenzhen) Limited --- the distinguished small molecular biologist and director of Niumanjiang small molecules laboratory.

In hypoxia environment, both body metabolism and oxygen metabolism obviously slow down or become disordered, which subsequently changes the dying rhythm and rate of cells ---- resulting in various hypoxia syndrome like dazzling, nausea, poor appetite, low working efficiency , body malfunction, lose of memory, thinking defect(or dottiness) heart throb, cerebra hypoxia edema, and cell death, etc.

The experiment conducted by Guangzhou Pharmacological Research Lab shows: through remarkably rises of the blood's oxygen content and oxygen availability, SDTL presents significant efficacy to resist blood hypoxia and hypobaric hypoxia, --- raising the survival rate and survival time of the laboratory animals subjected to hypobaric hypoxia by 75% and 96% respectively. It is an experiment of great clinical significance and practical value to the prevention of Qinghai-Tibet Plateau High Altitude Hypoxia, as well as of the High Altitude Hypoxia Syndrome.

The trial use by the volunteers exposed to hypoxia environment shows that SDTL Life-Biofactor can rapidly alleviate the hypoxia-caused high altitude reactions like dazzling, heart throb, breathing difficulty, and thinking defect, etc. So it is of great significance to the athletes and those from various fields who may suffer acute high altitude hypoxia, as well as to the people of different body condition who are ready to head for high plateau environment; SDTL is expected to thoroughly resolve the problem of high altitude hypoxia. Because of SDTL's innovative topical absorption process -- it penetrates into the blood through trans-microvessel and transbiogical cell membrane action. Therefore, this study has drawn great attention from many advanced countries throughout the world.

The botanic small molecule ingredients, after the processes of extraction, distillation, isolation, layer chromatography, and post-modification synergy, penetrates into the blood through capillary blood vessel , by using blood as a carrier and the transbiological cell membrane mode it directly acts on and enter human cells . This mechanism can prevent the damage caused by the gastric juice and the first passage effect of the liver. SDTL, with no oral or injection required, has been proved by toxicology experiment to be toxicity free and safe to use. After 15 minutes' application, SDTL can significantly improve and restore amino acid sequences and protein expression so as to raise the oxygenation ability of hemoglobin and oxygen-carrying capacity of Erythrocyte; as well as to promote Oxygen uptake rate and oxygen utilization of human body to a great degree!

Through microscope observation, we can clearly see the change of Erythrocyte in human blood before and after 15 minutes' application of SDTL: more active Erythrocyte, increased cell flexibility, reduced aggregation effect, obviously promoted capillary blood vessel permeating ability, and back-to-normal oxygen metabolism.

Theoretically, we can confirm that SDTL, by improving oxygen content in blood, has considerable efficacy on cell apoptosis and related diseases caused by hypoxia. It is of great significance to the clinical research and guidance on body constitution improvement and the aging of cells and organs. Hypoxia study is a major subject in the areas of disease treatment, anti-aging, and cell apoptosis mechanism; as the effect of Blood hypoxia on cells usually comes more serious than that of Ischemic, the increasingly serious high altitude hypobaric hypoxia has long been an urgent problem to be resolved in medical field.

By its obvious efficacy to prevent blood and high altitude hypoxia, SDTL Life-Biofactor is expected to be another breakthrough achievement on anti-hypoxia study, following the discovery of "R. Rosea ". It will free people from the plight of high altitude hypoxia. More happily, the experiment of acute and chronic toxicity also shows: SDTL has no side effect, no addiction, and no drug resistance, and contains no such ingredients as ephedrine, caffeine, alkaloid, heavy metal, ¦Â-blocker, and hormone, etc.

Up to now, relevant lab experiments has proved that SDTL can be used in the treatment of various diseases, and, with its significant anti-free radicals effect, it can also be widely applied to treat the diseases and syndrome caused by different types of hypoxia like those happened in the cities or airtight offices.

According to Miss. Yang Que, the senior expert of Guangzhou Pharmaceutical Industrial Research Institute and deputy director of pharmacology lab: SDTL has been proved to have efficacy to resist hypoxia. She believes SDTL's functional mechanism is fairly unique and deserves further explored and studied, and in a way, some of them is difficult to be explained by the scientific knowledge nowadays. Such studies may have the possibility to explore some innovative medical theories which would enlighten, inspire and push forward the direction of Molecular Medicine study and would develop a cutting edge medicine research directory. This exclusively invention originated in China may probably be one of the main subjects in leading the world's Biomedicine study !

According Gu Wen Yong (Head of Lab of world famous biologist Niu Man Jiang Lab), SDTL Life Biofactor 's wide spectrum anti-hypoxia characteristics shows infinite prospect on the treatment of hypobaric hypoxia and other related diseases. If applying it to promote the body constitution of all adolescent in our country for their intelligence development, constitution improvement, and memory enhancement. It will forever benefit the whole nation by lifting the body constitution of the people!

(People's Daily online Jan. 4, 2007)